Business & Tech
CooperSurgical Acquires Embryo Options
Best-in-class digital solution helps IVF clinics improve efficiency and educate patients about embryo management.
Press release from CooperSurgical:
Jan. 6, 2021
CooperSurgical, a leading provider of women’s health care solutions, has acquired Embryo Options, an established leader in cryo-storage software solutions for clinics and patients. The acquisition complements CooperSurgical’s comprehensive portfolio of innovative fertility offerings.
Find out what's happening in Trumbullfor free with the latest updates from Patch.
Clinics partnered with Embryo Options benefit from automated billing and streamlined management of cryo-preserved embryos, eggs, and sperm, resulting in increased collections, decreased specimen abandonment, and a reduced cost to manage cryo-inventory.
Embryo Options also assists IVF centers with educating patients on their options for cryopreserved embryos, eggs, and sperm. Patients using the Embryo Options platform have access to online resources to learn more about continuing to store specimens, for subsequent ART treatment cycles, thawing and discarding, or donating specimens to other patients or for research.
Find out what's happening in Trumbullfor free with the latest updates from Patch.
It has been estimated that more than 1 million cryopreserved embryos are currently being stored in the United States, and with the number of IVF cycles continuing to grow, this number is expected to increase significantly in the future.
“Embryo Options is a great addition to our portfolio of world-class solutions for assisted reproduction. Cryopreservation is an important and growing aspect of fertility offerings,” said Holly Sheffield, President, CooperSurgical. “I’m excited that Embryo Options furthers our goal of expanding patients’ access to the information and support they need to have a child.”
Embryo Options joins the CooperSurgical portfolio, which supports patient and clinicians’ needs throughout the entire fertility journey. Its brands include Origio®, Research Instruments®, TPC®, K-Systems®, Wallace® LifeGlobal® and CooperGenomicsSM.
“Our team is excited to join with CooperSurgical in bringing valuable new solutions to IVF facilities,” said Andy Gairani, Managing Director of Embryo Options. “The more we can expand our reach, the more we can help patients find solutions that are the right fit for them.”
This press release was produced by CooperSurgical. The views expressed here are the author's own.